RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Leveraged Buyouts

A collection of news and information related to Leveraged Buyouts published by this site and its partners.

Top Leveraged Buyouts Articles see all

Displaying items 1-5
  • Activision CEO faced firing during Vivendi buyout talks

    Activision CEO faced firing during Vivendi buyout talks
    Bobby Kotick, chief executive at video game publisher Activision Blizzard Inc. (think "Call of Duty" and "World of Warcraft"), saw his job threatened last year when he refused to accept the sale of some of Activision's shares to anyone but a group he controlled, according to court documents.
  • Allergan to slash workforce by 1,500

    Allergan to slash workforce by 1,500
    Botox maker Allergan Inc. said Monday that it will cut 1,500 employees, most of them in Southern California, in a cost-cutting effort the Irvine company hopes will help it fight off a hostile takeover bid by a Canadian rival. Stung by criticism that it'...

    Ackman and Valeant make bid for Allergan

    Ackman and Valeant make bid for Allergan
    Activist investor Bill Ackman and his unlikely Canadian partner, Valeant Pharmaceuticals International Inc., unveiled details of their bid for Irvine pharmaceutical company Allergan Inc., which makes the popular Botox wrinkle treatment. Valeant will...

    Allergan adopts 'poison pill' defense in Valeant takeover bid

    Takeover target Allergan Inc., the company that makes Botox, has adopted a "poison pill" defense intended to delay a buyout by Canadian company Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman. The Irvine company's...

    Allergan urges shareholders to reject Valeant offer

    Allergan Inc., the Irvine company that makes Botox, is urging shareholders to reject a buyout offer from a Canadian pharmaceutical firm. Valeant Pharmaceuticals International Inc. has offered to buy all of Allergan’s shares for a combination of...